Hong Kong, China

Chun Liang

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: The Hong Kong University of Science and Technology, Hong Kong Baptist University, Macau University of Science and Technology. Active years: 2008-2023.

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2008-2023

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Inventor Chun Liang

Introduction

Chun Liang is a notable inventor based in Hong Kong, CN. He has made significant contributions to the field of cancer treatment through his innovative research and patented methods. With a total of 2 patents, his work focuses on advancing therapeutic strategies for hyperproliferative conditions.

Latest Patents

Chun Liang's latest patents include a method and compounds for inhibiting the MCM complex and their application in cancer treatment. This method involves using an agent capable of inhibiting the functionality of the MCM complex, which is crucial in DNA replication. Additionally, he has developed a method of screening for such agents by detecting the locations and functions of the MCM subunits in cells treated with candidate compounds. Another significant patent is related to antisense oligonucleotides targeted to human CDC45. This patent discloses antisense oligonucleotides that inhibit the expression of the human replication-initiation protein. The methods outlined in this patent aim to prevent or treat hyperproliferative conditions by administering a therapeutically effective amount of these oligonucleotides.

Career Highlights

Chun Liang has worked at prestigious institutions such as The Hong Kong University of Science and Technology and Hong Kong Baptist University. His research has been instrumental in developing new approaches to cancer treatment, showcasing his commitment to advancing medical science.

Collaborations

Chun Liang has collaborated with notable colleagues, including Dao-rong Feng and Zhi-ling Yu. These partnerships have contributed to the success of his research and the development of his patents.

Conclusion

Chun Liang's innovative work in cancer treatment through his patented methods highlights his significant contributions to medical research. His dedication to finding effective solutions for hyperproliferative conditions positions him as a key figure in the field of biotechnology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…